Cargando…

Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial

BACKGROUND: Patients with acute myocardial infarction are at greater risk for chronic heart failure and mortality. Currently, there is limited evidence supporting the beneficial effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in non-diabetic patients with reduced left...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khiali, Sajad, Taban-Sadeghi, Mohammadreza, Sarbakhsh, Parvin, Khezerlouy-Aghdam, Naser, Namdar, Hossein, Salehi, Rezvanieh, Rezagholizadeh, Afra, Entezari-Maleki, Taher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557181/ https://www.ncbi.nlm.nih.gov/pubmed/37803449 http://dx.doi.org/10.1186/s13063-023-07682-6

Ejemplares similares

Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis
por: Rezagholizadeh, Afra, et al.
Publicado: (2021)

SARS-CoV-2 and probable lung cancer risk
por: Khiali, Sajad, et al.
Publicado: (2022)

Accessory Mitral Valve Misdiagnosed as Vegetation: A Case Report
por: Salehi, Rezvanieh, et al.
Publicado: (2022)

Anticoagulation in COVID-19: DDI Perspective
por: Khiali, Sajad, et al.
Publicado: (2020)

Tocilizumab in COVID-19 management: addressing time of starting treatment
por: Khiali, Sajad, et al.
Publicado: (2023)

Isotretinoin; A review on the Utilization Pattern in Pregnancy
por: Khiali, Sajad, et al.
Publicado: (2018)

The pattern and risk factors associated with adverse drug reactions induced by Reteplase in patients with acute ST-elevation myocardial infarction: The first report from Iranian population
por: Aslanabadi, Naser, et al.
Publicado: (2015)

Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review
por: Khani, Elnaz, et al.
Publicado: (2021)

Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic
por: Khiali, Sajad, et al.
Publicado: (2022)

In-hospital mortality of patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting in Iranian population
por: Khalili, Ahmadali, et al.
Publicado: (2022)

Poor outcome following percutaneous balloon mitral valvotomy in patients with atrial fibrillation
por: Aslanabadi, Naser, et al.
Publicado: (2016)

Symptom recognition and treatment-seeking behaviors in women experiencing acute coronary syndrome for the first time: a qualitative study
por: Asghari, Elnaz, et al.
Publicado: (2022)

Effects of Music on Cardiovascular Responses in Men with Essential Hypertension Compared with Healthy Men Based on Introversion and Extraversion
por: Namdar, Hossein, et al.
Publicado: (2014)

Aortic shelf as a normal variant diagnosed primarily as the aortic dissection: A case report
por: Toufan Tabrizi, Mehrnoush, et al.
Publicado: (2020)

The Streptokinase Therapy Complications and its Associated Risk Factors in Patients with Acute ST Elevation Myocardial Infarction
por: Aslanabadi, Naser, et al.
Publicado: (2018)

Vitamin D Deficiency Predicts the ST Elevation Type of Myocardial Infarction in Patients with Acute Coronary Syndrome
por: Safaie, Naser, et al.
Publicado: (2018)

Role of circulatory leukocyte based indices in short-term mortality of patients with heart failure with reduced ejection fraction
por: Sadeghi, Mohammadreza Taban, et al.
Publicado: (2020)

Relationship Between Prohormone Brain Natriuretic Peptide (NT-proBNP) Level and Severity of Pulmonary Dysfunction in Patients With Chronic Congestive Heart Failure
por: Nazemiyeh, Masoud, et al.
Publicado: (2015)

Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction
por: Butler, Javed, et al.
Publicado: (2022)

Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists
por: Khani, Elnaz, et al.
Publicado: (2022)

A commentary on “Unexpected sudden rise of human monkeypox cases in multiple non-endemic countries amid COVID-19 pandemic and salient counteracting strategies: Another potential global threat?” (Int J Surg 2022;103:106705)
por: Khani, Elnaz, et al.
Publicado: (2022)

Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’
por: Khani, Elnaz, et al.
Publicado: (2023)

Enoxaparin’s potential mechanisms against SARS-CoV-2
por: Afsharirad, Bentelhoda, et al.
Publicado: (2023)

Thrombus in transit: traveling from the inferior vena cava to the left ventricle
por: Salehi, Rezvanieh, et al.
Publicado: (2014)

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes
por: Filippatos, Gerasimos, et al.
Publicado: (2022)

Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction: A Retrospective Study
por: Hao, Zhengyang, et al.
Publicado: (2022)

Cost-effectiveness of empagliflozin for the treatment of heart failure with reduced ejection fraction in China
por: Sang, Haiqiang, et al.
Publicado: (2022)

Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin
por: Aimo, Alberto, et al.
Publicado: (2022)

Empagliflozin in heart failure with preserved ejection fraction: first success in mission impossible
por: Sciatti, Edoardo, et al.
Publicado: (2022)

Cost-effectiveness of empagliflozin in heart failure patients irrespective of ejection fraction in England
por: Kolovos, Spyros, et al.
Publicado: (2023)

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
por: Butler, Javed, et al.
Publicado: (2021)

Multinational cost‐effectiveness analysis of empagliflozin for heart failure patients with ejection fraction >40%
por: Kolovos, Spyros, et al.
Publicado: (2023)

Hidden patterns among the fatally injured pedestrians in an Iranian population: application of categorical principal component analysis (CATPCA)
por: Jamali-Dolatabad, Milad, et al.
Publicado: (2021)

Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes
por: Iborra-Egea, Oriol, et al.
Publicado: (2019)

Empagliflozin improves cardiac function in heart failure with reduced ejection fraction independent of loading conditions
por: Liang, Bo, et al.
Publicado: (2020)

Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER‐like endpoint definitions
por: Anker, Stefan D., et al.
Publicado: (2022)

Cost-utility analysis of empagliflozin in heart failure patients with reduced and preserved ejection fraction in China
por: Tang, Yi, et al.
Publicado: (2022)

Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2022)

A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction
por: Tafazzoli, Ali, et al.
Publicado: (2022)

The Effect of Foot Reflexology on Amnesia in Patients Undergoing Electroconvulsive Therapy: A Randomized Clinical Trial
por: Alinejad Machiani, Saeed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ahoj8oen1i6v4tqev1hjefr2ct